Search

everythinglearnresearchcommunity

for

Search:↓

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Truncated LTBP-1 disrupts TGF-beta signaling, affecting hair growth.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Folliculin deficiency causes problems with cell division and positioning due to disrupted RhoA signaling and interaction with p0071.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

A new hand-held light therapy device was found to be safe and effective for treating mild-to-moderate acne.

A new mutation in the FLCN gene linked to Birt-Hogg-Dube syndrome was found, suggesting people with certain lung collapse should be tested for this mutation and screened for kidney and colon cancer.

Fragile hair in children is rarely linked to trichothiodystrophy (TTD).

Adalimumab improved folliculitis decalvans in most patients.

The boy's severe skin disorder is caused by two new mutations in his TGM1 gene.

Early recognition and management of gastrointestinal tuberculosis in lupus patients are crucial to prevent complications.

BTNL proteins help control inflammatory bowel disease by maintaining specific immune cells.

Phosphorylation controls TFEB's location in the cell, affecting cell metabolism and stress response.

Lactoferrin levels are lower in people with chronic hair shedding, suggesting supplements could help treat it.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

The protein folliculin, involved in a rare disease, works with another protein to control how cells stick together and their organization, and changes in this interaction can lead to disease symptoms.

The sensor accurately measures thallium ions in solutions with high selectivity.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

The study found that Temporal Triangular Alopecia often starts in early childhood, while Folliculitis Decalvans is characterized by tufted hairs and redness around hair follicles.

Applying 2% tofacitinib cream helped some children with severe hair loss grow back hair.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Fractional infrared technology is effective and safe for treating cervical laxity.

LncRNA MTC boosts growth of goat skin cells, improving cashmere quality.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

A deficiency in the TTC7A gene causes immune problems, gut issues, and hair loss.

Temporal triangular alopecia is a lifelong condition with hairless patches on the side of the head that may be present from birth.

Trichoscopy is reliable for diagnosing Temporal Triangular Alopecia and can prevent unnecessary biopsies and wrong treatments.